The databases can--in a single day--test one disease-causing protein against a trillion chemical compounds and rank which ones are most likely to latch onto the protein and gum up its works.
The drug has attracted intense interest because it is one of the first compounds aiming to block protein clumps called amyloid from accumulating in the brains of Alzheimer's patients.